- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Two Cases of Lynch Syndrome That Were Diagnosed and Resected as Duodenal Cancer
-
- Abe Kodai
- Department of Surgery, Kitasato Institute Hospital, Kitasato University
-
- Suzuki Keiichi
- Department of Surgery, Kitasato Institute Hospital, Kitasato University
-
- Yahagi Masashi
- Department of Surgery, Kitasato Institute Hospital, Kitasato University
-
- Murata Takeru
- Department of Surgery, Kitasato Institute Hospital, Kitasato University
-
- Sako Hiroyuki
- Department of Surgery, Kitasato Institute Hospital, Kitasato University
-
- Ishii Yoshiyuki
- Department of Surgery, Kitasato Institute Hospital, Kitasato University
-
- Hara Atsuko
- Department of Diagnostic Pathology, Kitasato Institute Hospital, Kitasato University
Bibliographic Information
- Other Title
-
- 十二指腸癌を契機に診断し切除しえたLynch症候群の2例
Search this article
Description
<p>This report describes a 60-year-old man with a history of colorectal cancer, renal cell carcinoma, bladder cancer, and prostate cancer. His duodenal cancer was discovered as the sixth cancer and was treated by pancreaticoduodenectomy. He was given a diagnosis of Lynch syndrome based on his status as a carrier of pathogenic mutations in the MSH2 gene, which is a mismatch repair (MMR) gene. This report also describes a 75-year-old man with a history of multiple operations for colorectal cancer and gastric cancer. His duodenal cancer was discovered as the seventh cancer and was treated by pancreaticoduodenectomy. He was also given a diagnosis of Lynch syndrome based on his status as a carrier of pathogenic mutations in the MLH1 gene, which is an MMR gene. Lynch syndrome is a disease with autosomal dominant inheritance and is caused by mutations in MMR genes. The cumulative incidence of small bowel cancer, including duodenal cancer, is low; it is estimated to range from 2.5% to 4.3%. The guidelines for hereditary colorectal cancer recommend that surveillance in patients with gastrointestinal cancer should include endoscopic examinations every 1 to 2 years. However, in older patients such as those described herein, the risk of duodenal cancer should be kept in mind and surveillance should be performed more carefully and precisely.</p>
Journal
-
- The Japanese Journal of Gastroenterological Surgery
-
The Japanese Journal of Gastroenterological Surgery 52 (1), 27-35, 2019-01-01
The Japanese Society of Gastroenterological Surgery
- Tweet
Details 詳細情報について
-
- CRID
- 1390845713049088768
-
- NII Article ID
- 130007584910
-
- ISSN
- 13489372
- 03869768
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed